从形态学到分子验证:3PN来源胚胎的伦理再评估
辅助生殖中3PN受精卵长期被视为异常并建议丢弃,但部分3PN来源胚胎经分子验证为二倍体/整倍体,且有健康活产报道而无葡萄胎病例。本文提出在囊胚培养、PGT-A验证、伦理监督、扩大知情同意和长期随访框架下审慎推进研究。
要点
- 部分3PN来源胚胎经分子验证为二倍体/整倍体,挑战常规丢弃策略。
- 有遗传学确认的二倍体3PN胚胎移植后健康活产报道,无葡萄胎病例。
- 建议在伦理监督和长期随访下开展结构化研究以积累证据。
核心结论
- 基于形态学丢弃3PN来源胚胎可能丢弃染色体正常的潜在可存活胚胎,引发伦理关切。
研究设计与样本
- 本文为综述/评论性文章,汇总现有3PN来源胚胎的分子验证与移植结局证据并提出伦理研究框架。
主要发现
- 部分3PN来源胚胎呈现二倍体且整倍体染色体构成。
- 有遗传学确认的二倍体3PN来源胚胎移植后健康活产报道。
- 文献中未见3PN来源胚胎移植后葡萄胎妊娠病例报道。
临床怎么用
- 对胚胎有限的患者,可在伦理监督下考虑囊胚培养与PGT-A验证3PN来源胚胎而非直接丢弃。
- 实施扩大知情同意与长期随访以平衡安全与创新。
局限性
- 现有证据来自少量研究报道,缺乏 robust 临床证据以支持指南更新。
- 从自然妊娠三倍体推断辅助生殖风险的外推效度存疑。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In assisted reproduction, the presence of three pronuclei (3PN) in zygotes has long been considered a clear indicator of abnormal fertilization. Current international guidelines recommend the systematic discarding of 3PN-derived embryos due to presumed triploidy and the associated risk of molar pregnancy. However, some studies have demonstrated that a proportion of 3PN-derived embryos exhibit a diploid and euploid chromosomal constitution, with reports of healthy live births following the transfer of genetically confirmed diploid 3PN-derived embryos, and no documented cases of molar pregnancy. These findings challenge the theoretical risks inferred from naturally conceived triploid conceptuses and raise concerns regarding the validity of extrapolating risk estimates from spontaneous pregnancies to assisted reproduction settings. Morphology-based exclusion criteria may result in the discarding of potentially viable embryos despite molecular confirmation of chromosomal normality, thereby raising ethical issues related to beneficence and reproductive autonomy, particularly in patients with limited embryo availability. These considerations highlight the need for structured, ethically governed research pathways capable of generating the robust clinical evidence required to inform future guideline evaluation. In this paper, a cautious but proactive framework is proposed, incorporating blastocyst culture, validation by preimplantation genetic testing for aneuploidies, ethics committee oversight, extended informed consent and long-term follow-up to balance safety with innovation.
引用
- Alteri A, Campagnolo L, Klinger FG, et al. From morphology to molecular validation: ethical re-evaluation of 3PN-derived embryos. Reprod Biomed Online. 2026. PMID: 42659758. doi:10.1016/j.rbmo.2026.105888
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。